Adagrasib Shows Durable Benefit in KRAS-Mutated NSCLCAdagrasib shows durable clinical benefit in previously treated, advanced KRASG12C-mutated non-small cell lung cancer, including patients with brain metastases. Medscape Medical Newsadminjunio 5, 2022Uncategorized Adagrasib shows durable clinical benefit in previously treated, advanced KRASG12C-mutated non-small cell lung cancer, including patients with brain metastases. Medscape Medical News